Granite Investment Partners’s Champions Oncology CSBR Stock Holding History

Granite Investment Partners’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-102,501	Closed	-$579K	–	301
2019 Q3	$579K	Hold	102,501	–	–	0.03%	257
2019 Q2	$803K	Sell	102,501 -90,026	-47%	-$790K	0.04%	239
2019 Q1	$1.88M	Buy	192,527 +90,026	+88%	+$897K	0.11%	146
2018 Q4	$800K	Sell	102,501 -37,197	-27%	-$427K	0.06%	191
2018 Q3	$2.44M	Hold	139,698	–	–	0.14%	128
2018 Q2	$886K	Hold	139,698	–	–	0.06%	169
2018 Q1	$509K	Buy	+139,698	New	+$521K	0.03%	221

Other funds holding CSBR

BPI

Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Granite Investment Partners's CSBR Position: Q4 2019 in Review

Granite Investment Partners sold out of Champions Oncology (CSBR) in Q4 2019, closing a stake of 102,501 shares — an estimated $579K sold.

Granite Investment Partners first reported a position in CSBR in Q1 2018 and held it in 7 quarters. The position peaked at $2.44M in Q3 2018. 32 funds tracked by Wall St. Rank hold CSBR as of Q4 2019.

Granite Investment Partners reported no remaining Champions Oncology position as of Q4 2019 after selling out during the quarter.
Granite Investment Partners sold 102,501 Champions Oncology shares in Q4 2019, an estimated $579K.
Granite Investment Partners first reported a position in Champions Oncology in Q1 2018 and held it in 7 quarters.
Granite Investment Partners's Champions Oncology position peaked at $2.44M in Q3 2018.
32 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2019.

Based on Granite Investment Partners's 13F filing for Q4 2019, filed 10 Feb 2020.